Australia Pharmaceuticals

Clinuvel Pharmaceuticals Ltd (CUV)

Track

Track

Clinuvel Pharmaceuticals Ltd has recorded no insider trading activity within the past ninety days. The most recent transactions occurred on September 19, 2023, when Philippe Wolgen acquired shares. Previous historical filings indicate consistent buying patterns by key personnel, though these events date back more than three months.
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Philippe Wolgen Director
Transaction date
Purchase
Price
183.04
Quantity 51,634
Value A$513,209
Philippe Wolgen Director
Transaction date
Purchase
Price
252.80
Quantity 59,433
Value A$1,485,587
Jeffrey Rosenfeld Director
Transaction date
Purchase
Price
331.31
Quantity 77,810
Value A$4,639,710
Jeffrey Rosenfeld Director
Transaction date
Purchase
Price
19.10
Quantity 485
Value A$9,264
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-09-20 2023-09-19 B Purchase Philippe Wolgen Director
51,634
183.04
A$513,209 		51,634 183.04 A$513,209
2023-06-28 2023-06-26 B Purchase Philippe Wolgen Director
59,433
252.80
A$1,485,587 		59,433 252.80 A$1,485,587
2022-11-07 2022-11-04 B Purchase Jeffrey Rosenfeld Director
77,810
331.31
A$4,639,710 		77,810 331.31 A$4,639,710
2022-03-02 2022-02-25 B Purchase Jeffrey Rosenfeld Director
485
19.10
A$9,264 		485 19.10 A$9,264
Explore more

More insider trading research around Clinuvel Pharmaceuticals Ltd

More insider trades in Australia
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in Asia-Pacific